Vanguard Group Inc Edgewise Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,516,063 shares of EWTX stock, worth $139 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,516,063
Previous 4,508,166 0.18%
Holding current value
$139 Million
Previous $81.2 Million 48.45%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.88 - $29.5 $125,404 - $232,961
7,897 Added 0.18%
4,516,063 $121 Million
Q2 2024

Aug 13, 2024
BUY
$15.08 - $21.23 $7.4 Million - $10.4 Million
490,733 Added 12.22%
4,508,166 $81.2 Million
Q1 2024

May 10, 2024
BUY
$9.25 - $19.97 $17.5 Million - $37.8 Million
1,892,053 Added 89.02%
4,017,433 $73.3 Million
Q4 2023

Feb 14, 2024
BUY
$5.51 - $12.1 $335,884 - $737,603
60,959 Added 2.95%
2,125,380 $23.3 Million
Q3 2023

Nov 14, 2023
BUY
$5.73 - $7.69 $186,007 - $249,632
32,462 Added 1.6%
2,064,421 $11.8 Million
Q2 2023

Aug 14, 2023
BUY
$5.71 - $10.29 $149,225 - $268,918
26,134 Added 1.3%
2,031,959 $15.7 Million
Q1 2023

May 15, 2023
BUY
$6.66 - $11.33 $151,987 - $258,561
22,821 Added 1.15%
2,005,825 $13.4 Million
Q4 2022

Feb 10, 2023
BUY
$7.58 - $11.08 $1.75 Million - $2.56 Million
231,159 Added 13.2%
1,983,004 $17.7 Million
Q3 2022

Nov 14, 2022
BUY
$8.08 - $13.58 $4.24 Million - $7.13 Million
525,277 Added 42.82%
1,751,845 $17.2 Million
Q2 2022

Aug 12, 2022
BUY
$5.67 - $9.87 $87,743 - $152,738
15,475 Added 1.28%
1,226,568 $9.76 Million
Q1 2022

May 13, 2022
BUY
$9.1 - $18.97 $106,406 - $221,816
11,693 Added 0.97%
1,211,093 $11.7 Million
Q4 2021

Feb 14, 2022
BUY
$14.41 - $22.41 $8.82 Million - $13.7 Million
611,879 Added 104.15%
1,199,400 $18.3 Million
Q3 2021

Nov 12, 2021
BUY
$14.11 - $24.1 $65,724 - $112,257
4,658 Added 0.8%
587,521 $9.75 Million
Q2 2021

Aug 13, 2021
BUY
$21.33 - $30.25 $12.4 Million - $17.6 Million
582,863 New
582,863 $12.4 Million

Others Institutions Holding EWTX

# of Institutions
191
Shares Held
100M
Call Options Held
2.17M
Put Options Held
410K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.94B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email